Search results for "Prostate biopsy"

showing 10 items of 39 documents

Outcome of radical prostatectomy for incidental carcinoma of the prostate

2009

OBJECTIVE To evaluate a contemporary series of patients with incidental prostate cancer detected by transurethral resection of the prostate (TURP) and undergoing radical prostatectomy (RP). PATIENTS AND METHODS Between 1998 and 2004, 1931 patients had TURP for obstructive voiding symptoms and suspected BPH. Incidental prostate cancer was found in 104 (5.4%); 26 of these patients had a RP. The pathological staging and treatment of these patients were reviewed retrospectively and the follow-up results obtained. RESULTS Of the 26 patients who had RP, 17 had T1a and nine had T1b carcinoma of the prostate. After RP, six (35%) in the T1a group had no residual tumour (pT0) and 11 (65%) had pT2 can…

Malemedicine.medical_specialtyProstate biopsyUrologymedicine.medical_treatmentPathological stagingProstatic HyperplasiaUrologyurologic and male genital diseasesProstate cancerProstatemedicineHumansAgedTransurethral resection of the prostateProstatectomyIncidental Findingsmedicine.diagnostic_testbusiness.industryProstatectomyProstatic NeoplasmsCancerMiddle AgedProstate-Specific Antigenmedicine.diseaseTreatment Outcomemedicine.anatomical_structureHormonal therapyEpidemiologic MethodsbusinessProstatismBJU International
researchProduct

Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.

2008

We determined indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.Of 316 cystoprostatectomy specimens concomitant prostate cancer was diagnosed in 21.5%. Prostate cancer was diagnosed preoperatively in 24% of cases (evident prostate cancer), 32% were suspicious for prostate cancer but no biopsy was done (suspected prostate cancer) and in 44% prostate cancer was incidental. Patients were stratified into probability groups of intermediate/high risk prostate cancer by digital rectal examination and prostate specific antigen. The incidence of unfavorable histopathology was determined in each group.Of prostate cancers 85% were organ c…

Malemedicine.medical_specialtyProstate biopsyUrologymedicine.medical_treatmentUrologyCystectomyRisk AssessmentCystoprostatectomyCohort StudiesProstate cancerProstatePredictive Value of TestsPreoperative CaremedicineHumansAgedNeoplasm StagingRetrospective StudiesAged 80 and overProstatectomyCarcinoma Transitional CellUrinary bladderBladder cancermedicine.diagnostic_testbusiness.industryBiopsy NeedleProstateCancerProstatic NeoplasmsNeoplasms Second PrimaryMiddle AgedProstate-Specific Antigenmedicine.diseaseCombined Modality TherapyImmunohistochemistrySurvival AnalysisProstate-specific antigenmedicine.anatomical_structureTreatment OutcomeUrinary Bladder NeoplasmsbusinessFollow-Up StudiesThe Journal of urology
researchProduct

Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Bio…

2022

Our study aimed to compare the incidence of infective complications after transrectal ultrasound-guided prostate biopsy (TRUSBx) when adopting different antimicrobial prophylaxis regimens. A multi-institutional cohort of 1150 patients who underwent TRUSBx was retrospectively analyzed. Procedures were performed between 2017 and 2019 (before and after the EMA warning about the use of fluoroquinolones for the antibiotic prophylaxis of patient candidates to TRUSBx). The primary endpoint was the occurrence of infective complications, including sepsis and/or fever. The population was stratified according to the antibiotic prophylaxis adopted: fluoroquinolones (levofloxacin, ciprofloxacin, prulifl…

Microbiology (medical)Infectious Diseasesantibiotic prophylaxisantibiotic prophylaxis; fluoroquinolones; prostate biopsyantibiotic prophylaxiprostate biopsy; antibiotic prophylaxis; fluoroquinolonesPharmacology (medical)prostate biopsyfluoroquinolonesGeneral Pharmacology Toxicology and PharmaceuticsfluoroquinoloneBiochemistryMicrobiology
researchProduct

Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancer

2011

Objectives:  Accurate tumor grading on prostate biopsy represents the mainstay for therapy planning. Biopsy undergrading is a persistent diagnostic dilemma with therapeutic relevance. We questioned whether Gleason grading combined with an established alternative grading system incorporating cytological parameters improves grading accuracy. Methods:  Needle biopsies of 968 patients and the corresponding radical prostatectomy specimens were graded according to the Gleason grading system. In addition, all biopsies were graded according to the histo- and cytological grading system of Helpap. Biopsy Gleason grade, as well as the combined Gleason/Helpap grade, was compared with the final Gleason …

OncologyGleason grading systemmedicine.medical_specialtyNeoplasm GradingProstate biopsymedicine.diagnostic_testProstatectomybusiness.industryUrologymedicine.medical_treatmenturologic and male genital diseasesmedicine.diseaseGleason Score 6Prostate cancerInternal medicineBiopsymedicineRadiologyGrading (education)businessneoplasmsInternational Journal of Urology
researchProduct

Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate…

2014

OncologyMalemedicine.medical_specialtyPathologyProstate biopsymedicine.diagnostic_testbusiness.industryUrologyProstateProstatic NeoplasmsProstate-Specific Antigenmedicine.diseaseObesityProstate-specific antigenInternal medicineProstatic NeoplasmmedicineHumansObesitybusinessHumanInternational journal of urology : official journal of the Japanese Urological Association
researchProduct

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

2015

Background: PCA3 has been included in a nomogram outperforming previous clinical models for the prediction of any prostate cancer (PCa) and high grade PCa (HGPCa) at the initial prostate biopsy (IBx). Our objective is to validate such IBx-specific PCA3-based nomogram. We also aim to optimize the use of this nomogram in clinical practice through the definition of risk groups. Methods: Independent external validation. Clinical and biopsy data from a contemporary cohort of 401 men with the same inclusion criteria to those used to build up the reference’s nomogram in IBx. The predictive value of the nomogram was assessed by means of calibration curves and discrimination ability through the area…

PCA3MaleCancer Researchmedicine.medical_specialtyProstate biopsyBiopsyUrologyurologic and male genital diseasesRisk AssessmentDecision Support TechniquesCohort StudiesProstate cancerRisk groupsAntigens NeoplasmRisk FactorsGeneticsBiomarkers TumorMedicineHumansOpportunistic screeningAgedmedicine.diagnostic_testbusiness.industryArea under the curveExternal validationProstatic NeoplasmsOrgan SizeNomogramMiddle Agedmedicine.diseaseSurgeryNomogramsOncologybusinessBiomarkersResearch ArticleBMC cancer
researchProduct

Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatect…

2014

Purpose: miRNAs are noncoding RNAs that negatively regulate target mRNA gene expression. Aberrant miRNA expression is associated with prostate cancer pathogenesis. We identified miRNAs as potential biomarkers for prostate cancer diagnosis and prognosis. Materials and Methods: Total RNA was obtained from 10 normal prostate and 50 prostate cancer samples, and analyzed using the GeneChip (R) miRNA 2.0 Array. At a median followup of 92 months (range 2 to 189) an independent cohort of 273 paraffin embedded prostate cancer samples was used for validation by quantitative reverse transcriptase-polymerase chain reaction. Another 92 urine samples from patients undergoing prostate biopsy were evaluate…

PCA3OncologyMalemedicine.medical_specialtyPathologyProstate biopsydiagnosisUrologymedicine.medical_treatmentprostatic neoplasmsProstate cancerProstateInternal medicinemicroRNAmedicineBiomarkers TumorHumansAgedRetrospective StudiesProstatectomymedicine.diagnostic_testbusiness.industryProstatectomyProstatic Neoplasmsmedicine.diseasePrognosismicroRNAsGene Expression Regulation NeoplasticProstate-specific antigenMicroRNAsmedicine.anatomical_structureReal-time polymerase chain reactionEarly Diagnosisprognosisbusinessbiological markersThe Journal of urology
researchProduct

A Non-linear Diffeomorphic Framework for Prostate Multimodal Registration

2011

International audience; This paper presents a novel method for non-rigid registration of prostate multimodal images based on a nonlinear framework. The parametric estimation of the non-linear diffeomorphism between the 2D fixed and moving images has its basis in solving a set of non-linear equations of thin-plate splines. The regularized bending energy of the thin-plate splines along with the localization error of established correspondences is jointly minimized with the fixed and transformed image difference; where, the transformed image is represented by the set of non-linear equations defined over the moving image. The traditional thin-plate splines with established correspondences may p…

Prostate biopsyPhysics::Medical Physics[INFO.INFO-IM] Computer Science [cs]/Medical ImagingImage registration02 engineering and technology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicine[INFO.INFO-IM]Computer Science [cs]/Medical Imaging0202 electrical engineering electronic engineering information engineeringmedicineComputer visionThin plate splineMathematicsmedicine.diagnostic_test[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingbusiness.industryHigh-definition videoNonlinear systemSpline (mathematics)Hausdorff distanceComputer Science::GraphicsComputer Science::Computer Vision and Pattern Recognition020201 artificial intelligence & image processingDiffeomorphismArtificial intelligencebusiness
researchProduct

Texture Guided Active Appearance Model Propagation for Prostate Segmentation

2010

Fusion of Magnetic Resonance Imaging (MRI) and Trans Rectal Ultra Sound (TRUS) images during TRUS guided prostate biopsy improves localization of the malignant tissues. Segmented prostate in TRUS and MRI improve registration accuracy and reduce computational cost of the procedure. However, accurate segmentation of the prostate in TRUS images can be a challenging task due to low signal to noise ratio, heterogeneous intensity distribution inside the prostate, and imaging artifacts like speckle noise and shadow. We propose to use texture features from approximation coefficients of Haar wavelet transform for propagation of a shape and appearance based statistical model to segment the prostate i…

Prostate biopsymedicine.diagnostic_testbusiness.industryComputer scienceSpeckle noiseMagnetic resonance imagingPattern recognitionHaar waveletActive appearance modelShadowmedicineSegmentationComputer visionArtificial intelligencebusiness
researchProduct

Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica

2013

To reduce the number of negative prostate biopsies in patients with elevated PSA serum levels represents a major challenge in urological oncology. Angiogenetic factors might be involved in initial stages of prostate cancer and might represent useful tools in patients' selection for prostate biopsy. The plasmatic levels of Angiopoietin-2, Follistatin, G-CSF, HGF, IL-8, Leptin, PDGF-BB, PECAM-1 and VEGF were measured by BioPlex immunoassay in patients undergoing prostate biopsy for palpable prostate nodule and/or elevated PSA levels (≥4 ng/mL). They were related with biopsy results. ROC curve analysis was exploited to test the diagnostic accuracy of each biomarker by AUC calculation. A potent…

Prostate cancer Prostate biopsy Angiogenetic biomarker LeptinSettore MED/24 - Urologia
researchProduct